CHA University of Bundang

Gyeonggi-do 13496

0 studies enrolling now · 1 studies all time

What they study most

Head and Neck Cancer, Head and Neck Squamous Cell Carcinoma

Studies at this site

• Evorpacept (ALX148) in Combination With Pembrolizumab in Patients With Advanced Head and Neck Squamous Cell Carcinoma (ASPEN-03) — Running, not enrolling